Scott R. Ward - 19 Aug 2021 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Chairman and CEO, Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Scott R. Ward pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 19 Aug 2021
Net transactions value: -$999,907
Form type: 4
Filing time: 23 Aug 2021, 18:57:04 UTC
Previous filing: 17 Aug 2021
Next filing: 31 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Disposed to Issuer	$0	-27,842	-4.4%	$0.000000	601,966	19 Aug 2021	Direct	F1
transaction	CSII	Common Stock	Tax liability	$999,907	-27,637	-4.6%	$36.18	574,329	19 Aug 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CSII	Restricted Stock Units						34,297	19 Aug 2021	Common Stock	34,297		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of performance-based restricted stock granted in August 2018 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2019, 2020 and 2021 versus the Company's peer group.
F2	The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of the Company's common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.